You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 9, 2024

Details for Patent: 11,129,896

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 11,129,896 protect, and when does it expire?

Patent 11,129,896 protects XACIATO and is included in one NDA.

This patent has twelve patent family members in ten countries.

Summary for Patent: 11,129,896

Title:	Topical formulations and treatments
Abstract:	Provided is a pharmaceutical formulation and a method associated therewith for treating bacterial vaginosis. The pharmaceutical formulation includes from 10 to 25 weight parts of poloxamer F127, from 0.5 to 3.0 weight parts of xanthan gum, from 70 to 90 weight parts of water, and a therapeutically effective amount of a pharmaceutical active ingredient. The pharmaceutical formulation may also include from 0.5 to 1.5 weight parts of benzyl alcohol.
Inventor(s):	Alur; Hemant H. (Basking Ridge, NJ), Harwick; James A. H. (Tallassee, AL)
Assignee:	Trilogic Pharma LLC (Tallassee, AL)
Application Number:	15/746,012
Patent Claim Types: see list of patent claims	Use; Formulation;

Drugs Protected by US Patent 11,129,896

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Organon Llc	XACIATO	clindamycin phosphate	GEL;VAGINAL	215650-001	Dec 7, 2021		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				METHOD OF TREATING BACTERIAL VAGINOSIS BY SINGLE DOSE ADMINISTRATION OF A CLINDAMYCIN PHARMACEUTICAL GEL FORMULATION	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 11,129,896

PCT Information
PCT Filed	July 18, 2016	PCT Application Number:	PCT/US2016/042843
PCT Publication Date:	January 26, 2017	PCT Publication Number:	WO2017/015232

International Family Members for US Patent 11,129,896

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2993012	⤷ Try a Trial
Canada	3209380	⤷ Try a Trial
Denmark	3324938	⤷ Try a Trial
European Patent Office	3324938	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.